- Home
- TCRX vs GCV Comparison
TCRX vs GCV Comparison
Compare TCRX & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- GCV
- Stock Information
- Founded
- TCRX 2018
- GCV 1988
- Country
- TCRX United States
- GCV United States
- Employees
- TCRX N/A
- GCV N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- GCV Finance/Investors Services
- Sector
- TCRX Health Care
- GCV Finance
- Exchange
- TCRX Nasdaq
- GCV Nasdaq
- Market Cap
- TCRX 91.7M
- GCV 84.3M
- IPO Year
- TCRX 2021
- GCV N/A
- Fundamental
- Price
- TCRX $1.60
- GCV $4.03
- Analyst Decision
- TCRX Strong Buy
- GCV
- Analyst Count
- TCRX 5
- GCV 0
- Target Price
- TCRX $9.40
- GCV N/A
- AVG Volume (30 Days)
- TCRX 219.1K
- GCV 57.9K
- Earning Date
- TCRX 11-11-2025
- GCV 01-01-0001
- Dividend Yield
- TCRX N/A
- GCV 13.04%
- EPS Growth
- TCRX N/A
- GCV N/A
- EPS
- TCRX N/A
- GCV N/A
- Revenue
- TCRX $6,961,000.00
- GCV N/A
- Revenue This Year
- TCRX $255.18
- GCV N/A
- Revenue Next Year
- TCRX N/A
- GCV N/A
- P/E Ratio
- TCRX N/A
- GCV N/A
- Revenue Growth
- TCRX N/A
- GCV N/A
- 52 Week Low
- TCRX $1.02
- GCV $3.15
- 52 Week High
- TCRX $6.23
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- TCRX 36.40
- GCV 47.01
- Support Level
- TCRX $1.73
- GCV $4.00
- Resistance Level
- TCRX $1.96
- GCV $4.28
- Average True Range (ATR)
- TCRX 0.11
- GCV 0.05
- MACD
- TCRX -0.03
- GCV -0.01
- Stochastic Oscillator
- TCRX 0.00
- GCV 10.71
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.